Leukemia M3 is called acute promyelocytic leukemia, which can be cured by chemotherapeutic drugs, and there is no data to support how long it can live, which is related to the degree of progression of the disease, the effect of treatment, and the individual’s physique and other factors.
Acute promyelocytic leukemia is dominated by promyelocytes with increased bone marrow particles, typically characterized by anemia, bleeding, infection, and clinically selected retinoic acid + arsenic as the preferred treatment. If not effectively treated, death occurs within 2~3 months, and if the correct method is chosen in time, the survival rate is more than 5 years, and symptoms such as infection and hemorrhage will also affect the survival chances of patients.
Leukemia is mainly through the induction of remission treatment, as well as post-remission treatment based on preventing infection, components of blood transfusion, maintenance of nutrition, the patient’s disease progresses slowly, the symptoms are mild, get active and effective treatment, generally can get a longer survival period, is not easy to relapse, if the disease progresses more rapidly, the patient’s age and physical quality is poor, the effect of drug treatment is poor, the survival time will be relatively reduced.
Acute early childhood leukemia does not have specific data to support how long you can live, diagnosis of leukemia M3 type, should be timely medical treatment to improve the chances of survival. All of the above mentioned drugs should be used in accordance with medical advice.